Sentences with phrase «director of vaccine development»

Jury member Penny Heaton, director of vaccine development at the Bill & Melinda Gates Foundation, said CureVac's RNA technology had «the potential for a large and positive impact on public health,» in a statement released by the company on 10 March.

Not exact matches

Maria Elena Bottazzi leads the research, education and administration efforts of the school, is a Professor of Pediatric Tropical Medicine and the Deputy Director for the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development.

«The pace of preclinical and early clinical development for Zika vaccines is unprecedented,» said Barouch, corresponding author and director of the Center for Virology and Vaccine Research at BIDMC.

«We have been struggling to use traditional vaccine - development approaches with these big pathogens,» says Julie Louise Gerberding, president of the vaccine division at Merck and former director of the US Centers for Disease Control and Prevention.

«Taken together, these two studies suggest that the new scalable vaccine formulation is likely to prove as effective as the original formulation — which would make it the first protective TB vaccine in humans since BCG, which was introduced almost a century ago,» said Professor Ajit Lalvani, Director of the Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London and a member of the DAR - 901 development team.

In October, NIH director Francis Collins suggested that government spending reductions that hit the NIH delayed the development of an effective Ebola vaccine, and his remarks have made the agency a target on Capitol Hill.

Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likely will be necessary to achieve a durable end to the HIV / AIDS pandemic, according to a new commentary from Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The vaccine technology clearly has a biological effect that prevents dengue,» says Derek Wallace, regional director of clinical development for Sanofi Pasteur, the French pharmaceutical firm developing the vaccine, who reported results online today at The Lancet.

Trained as a physician, specialised in epidemiology, clinical pharmacology and vaccinology, Dr Odile Leroy has spent most of her carrier in vaccine development, as a scientist in Africa for nine years, as corporate clinical director of airborne vaccines for 10 years at Sanofi Pasteur.

Afterwards, Tom spent two years working at LigoCyte pharmaceuticals, where he served as Director of Process Development and Project Leader in the Norovirus vaccine program.

Since immune responses to vaccines can differ around the world, these findings are encouraging for the development of an effective Ebola vaccine for Africa,» said Merlin Robb, M.D., Director for Clinical Research at the US Military HIV Research Program (MHRP), whose site in Uganda, Makerere University Walter Reed Project (MUWRP), conducted the study.

It remains unclear exactly what this new organization will do.2 Such lack of clarity did not stop Lee Jong - wook, the World Health Organization's director - general, from calling it «a new political and financial dimension» to HIV vaccine development.

«Now that we know that [the difference] exists, it contributes to our understanding of why the vaccine is not effective in all cases and informs future vaccine development efforts,» said Dr. Dan Neafsey, associate director of the Genomic Center for Infectious Diseases at the Broad and co-first author of the study.

Dr Odile Leroy, Executive Director of the European Vaccine Initiative (EVI) and coordinator of TRANSVAC2, said: «The TRANSVAC2 activities will further strengthen the vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges&Vaccine Initiative (EVI) and coordinator of TRANSVAC2, said: «The TRANSVAC2 activities will further strengthen the vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges&vaccine R&D infrastructure in Europe and will thereby accelerate the development of effective vaccines that are urgently needed to address global health challenges».

She was assistant scientific director of Transgene S.A., France, where she managed several human or veterinary vaccine projects, and notably the development of a recombinant rabies vaccine this is widely used for the eradication of this disease in wild animals.

Before joining EDCTP, Prof. Mgone was the Network Director of the African Malaria Network Trust (AMANET) responsible for coordinating capacity development and networking in accelerating the development and assessment of malaria vaccines and other interventions.

«The approval of a vaccine to treat cancer is a victory in the history of cancer therapy, and signals the beginning of a new era in cancer medicine,» said Jill O'Donnell - Tormey, Ph.D., executive director of the U.S. - based Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that has provided decades of significant support to cancer immunology researchers around the world so that the development of cancer immunotherapies such as Dendreon's Provenge might one day be possible.